Immune reconstitution syndrome and fungal infections

Current Opinion in Infectious Diseases

Volumn 24, Issue 6, 2011, Pages 527-533

  Gupta, Ashish O ^a   Singh, Nina ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Fungal infections; HIV; Immune reconstitution syndrome; Mycoses; Transplants

Indexed keywords

ADALIMUMAB; ALEMTUZUMAB; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ECHINOCANDIN B; ETANERCEPT; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 8; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; VORICONAZOLE;

ARACHNOIDITIS; ASEPTIC MENINGITIS; ASPERGILLOSIS; BRAIN DAMAGE; CANDIDIASIS; CD4+ T LYMPHOCYTE; CELLULITIS; CHRONIC LYMPHATIC LEUKEMIA; COCCIDIOIDES; COUGHING; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DIPODASCUS CAPITATUS; DISEASE ASSOCIATION; DYSPNEA; GRANULOMA; HELPER CELL; HEMOPTYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMOSIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; HYPOXIA; IATROGENIC DISEASE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFLAMMATION; LEUKEMIA; LUNG INFILTRATE; LYMPHADENITIS; MYCOBACTERIUM AVIUM; MYCOSIS; NONHUMAN; PENICILLIUM MARNEFFEI; PLEURA EFFUSION; PNEUMOCYSTIS JIROVECI; PREGNANT WOMAN; REVIEW; SPOROTHRIX SCHENCKII; TH17 CELL; TH2 CELL; THORAX PAIN; TUBERCULOSIS; UPREGULATION; UVEITIS;

HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOCOMPROMISED HOST; MYCOSES; OPPORTUNISTIC INFECTIONS;

EID: 80055009914     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32834ab20a     Document Type: Review

References (71)

1. Hage CA, Bowyer S, Tarvin SE, et al. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 2010; 50:85-92.
2. Miceli MH, Maertens J, Buve K, et al. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description, and clinical and research implications. Cancer 2007; 110:112-120. (Pubitemid 46986424)
3. Muller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: A systematic review and meta-analysis. Lancet Infect Dis 2010; 10:251-261.
4. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453:1051-1057. (Pubitemid 351871737)
5. Belkaid Y, Tarbell K. Regulatory T cells in the control of host-microorganism interactions (+). Annu Rev Immunol 2009; 27:551-589.
6. Montes M, Sanchez C, Lewis DE, et al. Normalization of FoxP3(+) regulatory T cells in response to effective antiretroviral therapy. J Infect Dis 2011; 203:496-499.
7. Nilsson J, Boasso A, Velilla PA, et al. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006; 108:3808-3817. (Pubitemid 44864563)
8. Bourgarit A, Carcelain G, Samri A, et al. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells. J Immunol 2009; 183:3915-3923.
9. Elliott JH, Vohith K, Saramony S, et al. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis 2009; 200:1736-1745.
10. Barber DL, Mayer-Barber KD, Antonelli LR, et al. Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. Blood 2010; 116:3485-3493.
11. Seddiki N, Sasson SC, Santner-Nanan B, et al. Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol 2009; 39:391-403.
12. Hartigan-O'Connor DJ, Jacobson MA, Tan QX, Sinclair E. Development of cytomegalovirus (CMV) immune recovery uveitis is associated with Th17 cell depletion and poor systemic CMV-specific T cell responses. Clin Infect Dis 2011; 52:409-417.
13. Tan DB, Yong YK, Tan HY, et al. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med 2008; 9:307-316. (Pubitemid 351517278)
14. Sun HY, Singh N. Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients. Curr Opin Infect Dis 2009; 22:394-402.
15. Antinori S, Corbellino M, Necchi A, et al. Immune reconstitution inflammatory syndrome associated with Aspergillus terreus pulmonary infection in an autologous stem cell transplant recipient. Transpl Infect Dis 2010; 12:64-68.
16. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996; 173:321-329.
17. Todeschini G, Murari C, Bonesi R, et al. Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications. Eur J Clin Invest 1999; 29:453-457. (Pubitemid 29209766)
18. Haddow LJ, Colebunders R, Meintjes G, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis 2010; 10:791-802.
19. Lortholary O, Fontanet A, Memain N, et al. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005; 19:1043-1049. (Pubitemid 40961144)
20. Shelburne SA 3rd, Darcourt J, White AC Jr, et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:1049-1052. (Pubitemid 40418316)
21. Crespo G, Cervera C, Michelena J, et al. Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient. Liver Transpl 2008; 14:1671-1674.
22. Lanternier F, Chandesris MO, Poiree S, et al. Cellulitis revealing a cryptococcosis- related immune reconstitution inflammatory syndrome in a renal allograft recipient. Am J Transplant 2007; 7:2826-2828. (Pubitemid 350045770)
23. Singh N, Lortholary O, Alexander BD, et al. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis 2005; 40:1756-1761. (Pubitemid 40799944)
24. Cadena J, Thompson GR 3rd, Ho TT, et al. Immune reconstitution inflammatory syndrome after cessation of the tumor necrosis factor alpha blocker adalimumab in cryptococcal pneumonia. Diagn Microbiol Infect Dis 2009; 64:327-330.
25. Ingram PR, Howman R, Leahy MF, Dyer JR. Cryptococcal immune reconstitution inflammatory syndrome following alemtuzumab therapy. Clin Infect Dis 2007; 44:e115-e117.
26. Legrand F, Lecuit M, Dupont B, et al. Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis 2008; 46:696-702. (Pubitemid 351321553)
27. Saint-Faust M, Boyer C, Gari-Toussaint M, et al. Adjuvant corticosteroid therapy in 2 children with hepatosplenic candidiasis-related IRIS. J Pediatr Hematol Oncol 2009; 31:794-796.
28. Airas L, Paivarinta M, Roytta M, et al. Central nervous system immune reconstitution inflammatory syndrome (IRIS) after hematopoietic SCT. Bone Marrow Transplant 2010; 45:593-596.
29. Jazwinski A, Naggie S, Perfect J. Immune reconstitution syndrome in a patient with disseminated histoplasmosis and steroid taper: maintaining the perfect balance. Mycoses 2011; 54:270-272.
30. Barry SM, Lipman MC, Deery AR, et al. Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Med 2002; 3:207-211.
31. Godoy MC, Silva CI, Ellis J, et al. Organizing pneumonia as a manifestation of Pneumocystis jiroveci immune reconstitution syndrome in HIV-positive patients: report of 2 cases. J Thorac Imaging 2008; 23:39-43.
32. Jagannathan P, Davis E, Jacobson M, Huang L. Life-threatening immune reconstitution inflammatory syndrome after Pneumocystis pneumonia: A cautionary case series. AIDS 2009; 23:1794-1796.
33. Mori S, Polatino S, Estrada YMRM. Pneumocystis-associated organizing pneumonia as a manifestation of immune reconstitution inflammatory syndrome in an HIV-infected individual with a normal CD4+ T-cell count following antiretroviral therapy. Int J STD AIDS 2009; 20:662-665.
34. Gupta S, Mathur P, Maskey D, et al. Immune restoration syndrome with disseminated Penicillium marneffei and cytomegalovirus co-infections in an AIDS patient. AIDS Res Ther 2007; 4:21.
35. Ho A, Shankland GS, Seaton RA. Penicillium marneffei infection presenting as an immune reconstitution inflammatory syndrome in an HIV patient. Int J STD AIDS 2010; 21:780-782.
36. Saikia L, Nath R, Hazarika D, Mahanta J. Atypical cutaneous lesions of Penicillium marneffei infection as a manifestation of the immune reconstitution inflammatory syndrome after highly active antiretroviral therapy. Indian J Dermatol Venereol Leprol 2010; 76:45-48.
37. Ben-Ami R, Lewis RE, Kontoyiannis DP. Immunocompromised hosts: immunopharmacology of modern antifungals. Clin Infect Dis 2008; 47:226-235. (Pubitemid 351952889)
38. Bellocchio S, Gaziano R, Bozza S, et al. Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4. J Antimicrob Chemother 2005; 55:214-222. (Pubitemid 40331148)
39. Lamaris GA, Lewis RE, Chamilos G, et al. Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis 2008; 198:186-192. (Pubitemid 352019283)
40. Simitsopoulou M, Roilides E, Paliogianni F, et al. Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors. Antimicrob Agents Chemother 2008; 52:3301-3306.
41. Bicanic T, Meintjes G, Rebe K, et al. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: A prospective study. J Acquir Immune Defic Syndr 2009; 51:130-134.
42. Sungkanuparph S, Filler SG, Chetchotisakd P, et al. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: A prospective multicenter study. Clin Infect Dis 2009; 49:931-934.
43. Grant PM, Komarow L, Andersen J, et al. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS One 2010; 5:e11416.
44. Manabe YC, Campbell JD, Sydnor E, Moore RD. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007; 46:456-462. (Pubitemid 350098697)
45. Von Rango U. Fetal tolerance in human pregnancy - a crucial balance between acceptance and limitation of trophoblast invasion. Immunol Lett 2008; 115:21-32.
46. Singh N, Perfect JR. Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 2007; 45:1192-1199. (Pubitemid 47580319)
47. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 2008; 83:181-194. (Pubitemid 351303102)
48. Otahbachi M, Nugent K, Buscemi D. Granulomatous Pneumocystis jiroveci pneumonia in a patient with chronic lymphocytic leukemia: A literature review and hypothesis on pathogenesis. Am J Med Sci 2007; 333:131-135.
49. Legris T, Massad M, Purgus R, et al. Immune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient. Transplant Infect Dis 2011; 13:303-308.
50. Singh N, Lortholary O, Alexander BD, et al. Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection. Transplantation 2005; 80:1033-1039. (Pubitemid 41611924)
51. Lapusan S, Dimicoli S, Marjanovic Z, et al. Immune reconstitution inflammatory syndrome following Allo-SCT in a patient with Dipodascus capitatus spondylodiscitis. Bone Marrow Transplant 2010 [Epub ahead of print].
52. Galhardo MC, Silva MT, Lima MA, et al. Sporothrix schenckii meningitis in AIDS during immune reconstitution syndrome. J Neurol Neurosurg Psychiatry 2010; 81:696-699.
53. Mortimer RB, Libke R, Eghbalieh B, Bilello JF. Immune reconstitution inflammatory syndrome presenting as superior vena cava syndrome secondary to Coccidioides lymphadenopathy in an HIV-infected patient. J Int Assoc Physicians AIDS Care (Chic Ill) 2008; 7:283-285.
54. Breton G, Adle-Biassette H, Therby A, et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 2006; 20:119-121. (Pubitemid 41818123)
55. Boulware DR, Bonham SC, Meya DB, et al. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J Infect Dis 2010; 202:962-970.
56. Porter BO, Ouedraogo GL, Hodge JN, et al. D-dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS. Clin Immunol 2010; 136:42-50.
57. Dusso AS, Kamimura S, Gallieni M, et al. Gamma-interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: A mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab 1997; 82:2222-2232. (Pubitemid 27287588)
58. Rizzato G. Clinical impact of bone and calcium metabolism changes in sarcoidosis. Thorax 1998; 53:425-429. (Pubitemid 28261339)
59. Singh N. Hypercalcemia related to immune reconstitution in organ transplant recipients with granulomatous opportunistic infections. Transplantation 2006; 82:986. (Pubitemid 44564048)
60. Price P, Morahan G, Huang D, et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002; 16:2043-2047. (Pubitemid 35205268)
61. Benson CA, Kaplan JE, Masur H, et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 2004; 53:1-112.
62. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/ Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167:603-662.
63. Meintjes G, Wilkinson RJ, Morroni C, et al. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2010; 24:2381-2390.
64. Zhang TY, Daynes RA. Glucocorticoid conditioning of myeloid progenitors enhances TLR4 signaling via negative regulation of the phosphatidylinositol 3-kinase-Akt pathway. J Immunol 2007; 178:2517-2526. (Pubitemid 46233453)
65. Blackmore TK, Manning L, Taylor WJ, Wallis RS. Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis 2008; 47:e83-e85.
66. Sun HY, Singh N. Potential role of statins for the management of immune reconstitution syndrome. Med Hypotheses 2011; 76:307-310.
67. Broady R, Levings MK. Graft-versus-host disease: suppression by statins. Nat Med 2008; 14:1155-1156.
68. Chow SC. Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases. Arch Immunol Ther Exp 2009; 57:243-251.
69. Hamadani M, Awan FT, Devine SM. The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation. Blood 2008; 111:3901-3902.
70. Tleyjeh IM, Kashour T, Hakim FA, et al. Statins for the prevention and treatment of infections: A systematic review and meta-analysis. Arch Intern Med 2009; 169:1658-1667.
71. Makadzange AT, Ndhlovu CE, Takarinda K, et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa. Clin Infect Dis 2010; 50:1532-1538.